Evommune Overview
Evommune Target Price
Analysts' 12-month price predictions for EVMN.
Get informed when a big investor buys or sells
+ FollowShare Price
$19.83
Average Target Price
$53.00
167.3% upside
167.3% upside3 analysts in the last 4 months
High: $55 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | H.C. WainwrightMitchell Kapoor | $50 | 152.1% upside |  |
| 2026-05-11 | Morgan Stanley | $55 | 177.4% upside | |
| 2026-02-18 | Morgan StanleyJudah Frommer | $54 | 172.3% upside | |
| 2026-02-10 | Evercore ISI | $55 | 177.4% upside | |
| 2026-02-10 | H.C. WainwrightMitchell Kapoor | $65 | 227.8% upside | |
| 2026-01-22 | Oppenheimer | $42 | 111.8% upside | |
| 2026-01-07 | Raymond James | $40 | 101.7% upside | |
| 2026-01-06 | H.C. WainwrightMitchell Kapoor | $35 | 76.5% upside | |
| 2025-12-01 | Leerink PartnersThomas Smith | $42 | 111.8% upside | |
| 2025-12-01 | Evercore ISI | $40 | 101.7% upside | |
| 2025-12-01 | Morgan StanleyJudah Frommer | $36 | 81.5% upside | |